BioVie Inc. Investing Cash Flow
BioVie Inc. (BIVI) reported Investing Cash Flow of $14.53 million for the 12-month period ending 2024-06-30, per its S-1/A filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06
- BioVie Inc. net cash provided by (used in) investing activities for the quarter ending 2024-06-30 was $0.00.
- BioVie Inc. net cash provided by (used in) investing activities for the quarter ending 2024-03-31 was $0.00.
- BioVie Inc. net cash provided by (used in) investing activities for the quarter ending 2023-12-31 was $0.00.
- BioVie Inc. net cash provided by (used in) investing activities for the quarter ending 2023-09-30 was $14.53M.
- BioVie Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$14.30M.
- BioVie Inc. net cash provided by (used in) investing activities for fiscal 2016 was $9.91K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2024-06-30 | $0.00 derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $14.53M S-1/A · filed 2026-08-06 |
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-12 | $0.00 derived: sum of 2 quarters · filed 2025-05-12 | $14.53M 10-Q · filed 2025-05-12 | $12.73M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-11 | $14.53M 10-Q · filed 2025-02-11 | $12.73M derived: sum of 3 quarters · filed 2025-02-11 | |
| 2023-09-30 | $14.53M 10-Q · filed 2024-11-13 | $12.73M derived: sum of 2 quarters · filed 2024-11-13 | ||
| 2023-06-30 | -$1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | -$14.30M 10-K · filed 2024-09-30 | ||
| 2023-03-31 | -$12.50M 10-Q · filed 2024-05-14 | |||
| 2016-09-30 | $0.00 10-Q/A · filed 2017-01-19 | |||
| 2016-06-30 | $9.91K 10-K · filed 2017-08-24 | |||
| 2015-09-30 | $0.00 10-Q/A · filed 2017-01-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |